SKYE short interest
Skye Bioscience Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 147,954 |
|---|---|
| Change vs prior report | 30,868 (+26.4%) |
| Change over six months | -90.7% |
| Days to cover | 1.74 (sector: 3.78) |
| Average daily volume | 85,208 |
| Rank in Healthcare | #724 of 922 by days to cover |
SKYE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 147,954 | +26.4% | 1.74 | 85,208 |
| 2026-09-15 | 117,086 | -9.1% | 1.36 | 86,091 |
| 2026-08-31 | 128,781 | -89.3% | 1.00 | 217,817 |
| 2026-08-14 | 1,203,600 | -8.6% | 1.51 | 799,341 |
| 2026-07-31 | 1,316,797 | +24.9% | 12.56 | 104,833 |
| 2026-07-15 | 1,054,357 | +10.9% | 7.97 | 132,231 |
| 2026-06-30 | 950,654 | -2.5% | 7.15 | 133,002 |
| 2026-06-15 | 974,765 | -13.5% | 4.82 | 202,290 |
| 2026-05-29 | 1,126,334 | -11.2% | 6.61 | 170,323 |
| 2026-05-15 | 1,268,178 | -1.3% | 7.23 | 175,331 |
| 2026-04-30 | 1,284,390 | -11.9% | 5.24 | 244,960 |
| 2026-04-15 | 1,458,232 | -8.8% | 7.38 | 197,723 |
| 2026-03-31 | 1,598,033 | +1.6% | 6.91 | 231,135 |
| 2026-03-13 | 1,573,477 | +62.6% | 1.00 | 1,961,638 |
| 2026-02-27 | 967,400 | +5.0% | 4.80 | 201,653 |
| 2026-02-13 | 921,289 | -9.2% | 2.23 | 412,735 |
| 2026-01-30 | 1,014,976 | +6.3% | 5.99 | 169,503 |
| 2026-01-15 | 954,593 | -4.4% | 1.85 | 516,165 |
| 2025-12-31 | 998,730 | -7.2% | 1.44 | 695,830 |
| 2025-12-15 | 1,076,346 | +1.4% | 4.02 | 268,008 |
| 2025-11-28 | 1,061,071 | -31.0% | 4.03 | 263,481 |
| 2025-11-14 | 1,537,748 | -21.3% | 4.99 | 308,194 |
| 2025-10-31 | 1,952,988 | -16.3% | 3.57 | 546,922 |
| 2025-10-15 | 2,333,871 | -21.1% | 1.00 | 2,904,441 |
| 2025-09-30 | 2,957,160 | +7.7% | 8.06 | 366,715 |
import finzdata as yf
yf.Ticker("SKYE").short_interest # every report since 2017
yf.Client().short_interest(["SKYE"], start="2018-01-01")Healthcare short interest · SKYE price history · Who owns SKYE · All short interest